ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CELLULAR DISTRIBUTION;
CONTROLLED STUDY;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG MEGADOSE;
FIBROSING ALVEOLITIS;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
LUNG LAVAGE;
LYMPHOCYTE COUNT;
MALE;
MOUSE;
NONHUMAN;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN LOCALIZATION;
RAT;
SURVIVAL RATE;
Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)
American Thoracic Society
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161(2 Pt 1):646-64
Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4
Puente E, Saint-Laurent N, Torrisani J, et al. Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4. J Biol Chem 2001;276(16):13461-8
(2001)J Biol Chem, vol.276, Issue.16, pp. 13461-13468
Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells
Lang A, Sakhnini E, Fidder HH, et al. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int 2005;25(4):808-16